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Efforts to prevent human immunodeficiency virus
type 1 (HIV-1) infection would benefit from under-
standing the factors that govern virus neutralization
by antibodies. We present a mechanistic model for
HIV-1 neutralization that includes both virus and anti-
body parameters. Variations in epitope integrity on
the viral envelope glycoprotein (Env) trimer and Env
reactivity to bound antibody influence neutralization
susceptibility. In addition, we define an antibody-
specific parameter, the perturbation factor (PF),
that describes the degree of conformational change
in the Env trimer required for a given antibody to
bind. Minimally perturbing (low-PF) antibodies can
efficiently neutralize viruses with a broad range of
Env reactivities due to fast on-rates and high affinity
for Env. Highly perturbing (high-PF) antibodies inhibit
only viruses with reactive (perturbation-sensitive)
Envs, often through irreversible mechanisms. Ac-
counting for these quantifiable viral and antibody-
associated parameters helps to predict the observed
profiles of HIV-1 neutralization by antibodies with a
wide range of potencies.
INTRODUCTION
The human immunodeficiency virus type 1 (HIV-1) envelope
glycoprotein (Env) spike on the surface of virions binds host
cell receptors (CD4 and CCR5) and mediates virus entry by
fusing the viral and cell membranes (Wyatt et al., 1998). The
unliganded Env trimer exists in a metastable, high-potential-
energy state. During virus entry, this energy is channeled,
through a series of receptor-induced conformational changes
in Env, into the force required to fuse the viral and cell mem-
branes (Blumenthal et al., 2012).
During persistent HIV-1 infection, the Env complex is a primary
target for the antibody (Ab) response of the host. The HIV-1 EnvCell Host &surface is heavily glycosylated and exhibits variability among vi-
rus strains, minimizing the elicitation and efficacy of neutralizing
Abs (Wei et al., 2003; Zwick and Burton, 2007). Neutralizing Abs
generated by HIV-1-infected individuals vary tremendously in
breadth and potency (Mascola, 2009). Although persistent HIV-
1 variants typically escape these Abs, passive protection studies
suggest that neutralizing Abs can potentially prevent acquisition
of HIV-1 infection (reviewed in Montefiori and Mascola, 2009)
However, broadly neutralizing anti-HIV-1 Abs have been difficult
to elicit in vaccinated animals or humans (Mascola et al., 1996).
A complete understanding of the mechanism of Ab-mediated
neutralization of HIV-1 infection is lacking. Ab-mediated inhibi-
tion of HIV-1 infection depends upon the binding of Ab to the
functional Env spike on the virus surface (Chen et al., 2009;
Klasse and Sattentau, 2002; Parren et al., 1998; Sattentau and
Moore, 1995; Tong et al., 2012; Yang et al., 2006). However,
for a range of diverse HIV-1 variants and Abs, Ab binding to
Env inconsistently predicts the potency of virus neutralization,
suggesting that additional parameters contribute to virus inhibi-
tion.We recently identified a viral property, intrinsic Env reactivity
(ER), which influences the susceptibility of HIV-1 variants to inac-
tivation by Abs and other inhibitory ligands (Haim et al., 2011). ER
describes the propensity of the high-potential-energy, unli-
ganded Env trimer to transition to lower-energy states upon
perturbation. Viruses with high ER demonstrate global sensitivity
to inhibition by multiple Abs that target different epitopes on the
gp41 transmembrane and gp120 exterior Envs (Haim et al.,
2011). In addition, viruses with high ER are more sensitive to
cold-induced inactivation and more efficiently utilize low levels
of CD4 for entry. Naturally occurring HIV-1 variants exhibit a
wide range of apparently continuous ER values, which can be
estimated by measuring the sensitivity of virus entry to inhibition
by a given level of bound soluble CD4 (sCD4). The increases in
sensitivity of high-ER viruses to neutralization by multiple Abs
do not arise from globally increased formation or exposure of
the corresponding epitopes on Env (Haim et al., 2011). Thus,
the efficiency of HIV-1 neutralization can be influenced not only
by the affinity of Ab-Env binding, but also by ER to Ab binding.
In our previous study (Haim et al., 2011), we made the unex-
pected discovery that the impact of ER on the efficiency of





B Figure 1. Ab Interaction with Primary HIV-1
Env Trimers
(A and B) Correlation between binding of mono-
clonal Abs and CD4-Ig (at 2 mg/ml) to the cell
surface Envs of the AD8 (A) and JRFL (B) HIV-1
strains and the reciprocal of the Ab concentration
(in mg/ml) required for half-maximal inhibition of the
infection of viruses with the same Envs. Binding of
each Ab is expressed as a fraction of the binding of
the 2G12 Ab (at 2 mg/ml) to Env.
(C) Sampling frequency of the Env conformations
competent for binding the indicated monoclonal
Abs and CD4-Ig. Error bars = SEM.
(D) Effect of sCD4 binding (15 mg/ml) on the AD8
Env sampling frequency associated with the indi-
cated Abs. For the absolute binding values, see
Figure S1C.
(E) Correlation between the PF values measured
for each Ab on the AD8 and JRFL Envs. The 48d Ab
is excluded from this correlation due to the low
binding values for the JRFL Env. The symbols are
color coded based on PF (blue, low; red, high).
Spearman rank-order correlation coefficient, rS;
p value, two-tailed t test.
(F) PF values for the panel of Abs measured on the
AD8 and three clade C HIV-1 Envs. Asterisks
represent sampling frequencies that could not be
calculated due to undetectable Ab binding to that
Env.
(G) Spearman rank-order coefficients for correla-
tions between PF values of the Ab panel,
measured on clade B and C HIV-1 Envs. p values
are indicated in parentheses, and the boxes are
color coded according to the strength of the cor-
relation. Data are represented as mean ± SEM.
Figure 1 is related to Figure S1.
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Env and Antibody Factors in HIV-1 Neutralizationobservation suggested that unappreciated properties of anti-
Env Abs might limit the explanatory capabilities of current
models of neutralization. Here, we present a mechanistic model
for HIV-1 neutralization that includes both viral and Ab parame-
ters. We describe an Ab property that we designate the pertur-
bation factor (PF). This property quantitatively describes the
perturbation of Env conformation that is required for Ab binding.
Using this parameter, we derive an expression that predicts with
high accuracy the sensitivity of a given strain of HIV-1 to a given
Ab, employing three input parameters: (i) the efficiency of Ab
binding to the trimeric, membrane-bound Env; (ii) ER (a contin-
uous property of Env); and (iii) PF (a continuous property of Ab).548 Cell Host & Microbe 14, 547–558, November 13, 2013 ª2013 Elsevier Inc.RESULTS
Relationship between Ab-Env
Binding and Neutralization of
Primary HIV-1
Ab inhibition of HIV-1 infection is affected
by the efficiency of Ab binding to the Env
spike on the virus surface (Chen et al.,
2009; Klasse and Sattentau, 2002; Parren
et al., 1998; Sattentau and Moore, 1995;
Tong et al., 2012; Yang et al., 2006). We
studied the binding of Abs to the trimeric,
membrane-anchored form of Env fromtwo primary HIV-1 strains, AD8 and JRFL, expressed on the sur-
face of HOS cells. The AD8 and JRFL Envs exhibit near-com-
plete proteolytic maturation in HOS cells and thus better reflect
the antigenicity of the functional Env trimer (Haim et al., 2013;
Pancera and Wyatt, 2005). A panel of monoclonal Abs was
tested for the efficiency of Env binding and, in parallel, for the
ability to neutralize viruses pseudotyped with the AD8 and
JRFL Envs. A strong correlationwas observed between the bind-
ing of each Ab to Env expressed on the surface of HOS cells and
the capacity of the Ab to inhibit infection by viruses containing
that Env (Figures 1A and 1B). These correlations were signifi-
cantly better when binding was measured in HOS cells rather
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Env and Antibody Factors in HIV-1 Neutralizationthan in COS-1 or 293T cells (Figure S1A available online), reflect-
ing more efficient Env cleavage in HOS cells (Haim et al., 2013).
Therefore, for the primary AD8 and JRFL HIV-1 strains, Ab bind-
ing efficiency to the trimeric, membrane-bound, and cleaved Env
is directly related to neutralization potency.
Measurement of the Sampling Frequency of the Ab
Binding-Competent States of Env
Hypothetically, in its metastable unliganded state, the HIV-1 Env
trimer may sample different conformations, only some of which
allow the binding of a particular Ab. We define the sampling fre-
quency as the fraction of total Env molecules that is in a confor-
mation competent for binding theAb. To investigate the sampling
frequency associated with different Abs, we compared the bind-
ing of each Ab to glutaraldehyde (GA)-fixed and untreated Env on
the surface of transfected HOS cells. Binding efficiency of an Ab
to fixed Env relative to its binding to unfixed Env represents the
relative occupancy of those conformations competent for Ab
binding at a given time point (Yuan et al., 2006). To study Env
conformational sampling (and not the intactness of the epitope),
we tested only Abs that achieved measurable levels of binding.
The observed pattern of sampling frequencies associated with
the Abs was very similar for the AD8 and JRFL Envs (Figures
1C and S1B). The 48d and 17b Abs, which recognize CD4-
induced epitopes, bound very poorly to Env, and their binding
was further reduced upon GA fixation. By contrast, the binding
of several Abs increased after GA treatment. Apparently, in these
cases, limiting Env conformational change improves Ab binding,
suggesting that the unliganded Env trimer frequently samples
conformations recognized by these Abs. CD4 binding increased
the sampling frequency associated with the CD4-induced Abs
and the gp41 membrane-proximal external region (MPER)-
directed 2F5 and 4E10 Abs (Figures 1D and S1C). For other
Abs, such as PGT121 and 2G12, the sampling frequency was
similar in the unliganded and CD4-bound states of Env.
That CD4 binding to Env followed by GA treatment signifi-
cantly increased the binding of CD4-induced and anti-gp41
Abs suggested that GA fixation measures the frequency with
which the Env trimer samples conformational states compatible
with Ab binding, rather than reflecting an alteration of the target
epitopes through, for example, lysine modification. Similarly, we
previously observed that GA fixation of the gp120 Env core,
which lacks the V1, V2, and V3 loops, does not decrease the
binding of the Abs used in our study (Kwon et al., 2012). There-
fore, for these Abs, the ratio of Ab binding to fixed versus unfixed
Env reflects the frequency with which Env conformational states
competent for Ab binding are sampled.
The sampling frequency associated with each Ab epitope (i.e.,
the relative occupancy of those conformations that can bind the
Ab) is determined by the sum of the free energy of these confor-
mations relative to that of all sampled conformational states
(Guggenheim, 1955). Higher-energy conformations (i.e., confor-
mations that are more structurally perturbed relative to the basal
conformation of the molecule) are less frequently sampled.
Therefore, the greater the magnitude of structural change
required for Ab binding (i.e., the higher the energy state), the
lower its spontaneous sampling frequency. The degree of pertur-
bation required for Ab binding can be derived by calculating the
reciprocal of the measured sampling frequency and is hereinCell Host &designated the perturbation factor (PF). Our measured sampling
frequency and calculated PF provide indications of the Env
structural changes that are required for Ab binding, which are
often related to, but not identical with, the Env structural changes
that are induced by Ab binding (Hammes et al., 2009). Thus, for
example, although CD4 binding can induce dramatic structural
changes in Env, the high sampling frequency of its binding-
competent state indicates that minimal changes in Env are
required for the binding of this ligand (Figure 1C).
Although HIV-1 strain-dependent Env variation slightly influ-
enced the absolute PF values associated with each Ab, very
strong rank order correlations were observed among Ab PFs
calculated using different HIV-1 Env strains (Figure 1E and see
below). Apparently, the clade B Envs studied herein are suffi-
ciently similar so that the PF is primarily a property of the Ab.
Thus, anti-Env Abs can be classified according to their PF. The
Ab symbols are color coded in Figure 1E and throughout the
manuscript according to the PF (low PF, blue; high PF, red).
Comparison of Ab PFs Using Envs from Divergent Clade
B and Clade C HIV-1
To determine whether the PF values measured for the above
clade B strains are maintained in genetically diverse strains of
HIV-1, we examined the Envs of three clade C transmitted/
founder HIV-1 isolates from geographically distinct regions:
isolate ZM249M from Zambia, isolate 704809221 from South
Africa, and isolate 703010217 from Malawi (Figures 1F and
S1D). These clade C Envs were antigenically distinct from the
clade B Envs and were not recognized by several of the Abs
that recognized the AD8 and JRFL Envs. For the remainder of
the Abs, therewere very strong correlations among the PF values
measured both within the clade C group and with the clade B
AD8 Env (Figure 1G). The correlation between JRFL Env and
the clade C Envs was not as good as that of AD8, suggesting
that a limited level of variation in the PFs may exist. Interestingly,
the clade C isolates demonstrated significantly different PF
values for CD4-Ig, indicating that the Env state competent for
binding CD4 is differentially sampled in HIV-1 isolates. Overall,
despite limited variation, PF values are largely maintained across
diverse HIV-1 strains from clades B and C.
Effect of Ab PF on Binding and Inhibition of Primary
HIV-1 Envs
The on-rate of binding of some anti-Env Abs to the gp120 mono-
mer correlates with neutralization efficiency (Sattentau and
Moore, 1995; Steckbeck et al., 2005). To examine the relation-
ships among PF, Env binding, and HIV-1 neutralization, we
measured the on-rate of Ab binding to cell surface Env. Strong
inverse correlations were observed between the PF of the Ab
and its on-rate (Figure 2A) and between the PF and the steady-
state binding of the Ab to Env (Figure 2B). We then compared
the PF of each Ab with the efficiency with which it inhibited
HIV-1 infection. Analysis of the group of highly efficient Abs
that can achieve 90% or higher inhibition of the AD8 and JRFL
primary isolates revealed a very strong inverse correlation be-
tween the PF of each Ab and its virus-neutralizing potency (Fig-
ure 2C). Indeed, the inverse correlation between Ab PF and
neutralization potency was at least as strong as the positive cor-
relation between Ab-Env binding and neutralization efficiencyMicrobe 14, 547–558, November 13, 2013 ª2013 Elsevier Inc. 549
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Figure 2. Relationship between the Perturbation Factor and Ab On-Rate, Binding Efficiency, and Neutralization Potency
(A and B) Inverse correlation between the PF associated with each Ab and either the on-rate of the Ab (A) or the binding efficiency of the Ab (B) to AD8 Env.
(C and D) Correlation between either the Ab PF (C) or the Ab binding efficiency (D) measured on the AD8 and JRFL Envs and Ab neutralization of virus containing
these Envs. The AD8 (black-bordered symbols) and JRFL (red-bordered symbols) data are pooled. Data points are colored according to PF. Spearman rank-
order correlation coefficient, rS; p value, two-tailed t test.
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level of correlation between PF and neutralization potency (rS =
0.855, p value < 0.000001) was similar to that between binding
and neutralization potency (rS = 0.857, p value < 0.000001). Thus,
Ab-mediated neutralization depends upon the intactness of the
epitope (specific to the Env) and its degree of exposure (a prop-
erty of the epitope or the Ab). Given the integrity of the relevant
epitope, the degree of conformational perturbation of the unli-
ganded trimer that is required for the Ab to bind is inversely
related to the Ab on-rate and steady-state level of binding to
Env, which influence neutralization potency.
Ab Inhibition of Reactive and Nonreactive HIV-1 Env
Variants
For the AD8 and JRFL primary HIV-1 isolates, the efficiency with
which each Ab binds the Env trimer correlated strongly with its
capacity to inhibit infection by the corresponding virus. However,
many primary HIV-1 strains are more sensitive to Ab neutraliza-
tion (i.e., have higher ER values) than AD8 and JRFL (Haim et al.,
2011). We examined the binding and neutralization profiles of a
panel of Abs and CD4-Ig to a pair of closely matched HIV-1
Envs that differ in ER. The J3Hx(197) is a variant of the AD8
Env that lacks a potential N-linked glycosylation site at
Asn197, which increases the exposure of the coreceptor-binding
site (CoR-BS) (Kolchinsky et al., 2001a). Although this change
enhances the binding of Abs that target epitopes overlapping
the CoR-BS, sensitivity to these Abs is only minimally affected.
Thus, like AD8, from which it is derived, J3Hx(197) is a low-ER
Env and is relatively resistant to Ab neutralization and cold-
induced inactivation (Haim et al., 2011). As was seen for the550 Cell Host & Microbe 14, 547–558, November 13, 2013 ª2013 Elslow-ER AD8 and JRFL viruses, the neutralization of the
J3Hx(197) virus by each Ab strongly correlated with the binding
of the Ab to J3Hx(197) Env trimers (rS = 0.844, p value = 0.00004)
(Figure 3A). These Env binding and virus neutralization profiles
were compared with those of a J3Hx(197) variant, J3Hx
(197,HT,N), that contains two changes in gp41, NM625/626HT
and D674N. These gp41 changes minimally affect the binding
of most Abs to the Env trimer (Figure 3A) but have been shown
to significantly increase ER (Haim et al., 2011). A detailed
description of these changes is given in the Supplemental Exper-
imental Procedures.
Due to its high ER, the J3Hx(197,HT,N) virus was neutralized
very efficiently by many Abs, even those with low or modest
levels of binding to the J3Hx(197,HT,N) Env trimer (Figure 3A).
Compared with the neutralization of J3Hx(197), the IC50 values
(i.e., the concentration required for 50% inhibition of virus infec-
tion) of some Abs decreased by up to 4 orders of magnitude for
inhibition of the J3Hx(197,HT,N) virus. In contrast to J3Hx(197),
no correlation was observed between Env binding and virus
neutralization for J3Hx(197,HT,N) (rS = 0.066) (Figure 3A).
Furthermore, no correlation was observed between the
measured change in binding efficiency and the change in
neutralization of the two Env variants (data not shown).
The binding-neutralization profiles in Figure 3A suggest that
ER exerts varying effects on the virus-neutralizing potency of
different Abs, as previously observed (Haim et al., 2011). The
effect of ER on virus inhibition by each Ab can be measured by
the fold decrease in IC50 of the J3Hx(197,HT,N) virus relative to
that of the J3Hx(197) virus (Figure 3B). The impact of ER on virus
inhibition by each Ab was strongly associated with the efficiencyevier Inc.
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Figure 3. Ab-Env Binding, PF and Neutralization of AD8 Variants that
Differ in Env Reactivity
(A) Relationship between Ab binding and inhibition of two AD8 Env variants that
differ in the level of ER. Light blue lines are drawn between data points rep-
resenting the same Ab tested with the two Envs. Abs with an IC50 value greater
than 20 mg/ml were assigned a neutralization value of 0.05.
(B) Fold increase in neutralization sensitivity (1/IC50) of J3Hx(197,HT,N) relative
to J3Hx(197) for the indicated Abs and CD4-Ig. The colors of the bars indicate
the PF values of the Abs, measured on the AD8 Env.
(C and D) Correlations between either the Ab binding efficiency (C) or the Ab PF
(D) measured on the J3Hx(197) Env and the fold increase in neutralizing
potency (1/IC50) for J3Hx(197,HT,N) relative to J3HX(197). Spearman rank-





Figure 4. Ab-Env Binding, PF, and Neutralization of HXBc2 Variants
with Different ER Values
(A) Relationship between Ab binding and inhibition of the high-ER HXBc2 Env
and the low-ER HXBc2(DQR) Env. Abs that had a measured IC50 value greater
than 30 mg/ml were assigned a neutralization value of 0.03.
(B) Fold increase in neutralization sensitivity (1/IC50) of virus containing
the HXBc2 Env relative to the HXBc2(DQR) Env for the indicated Abs and CD4-
Ig. The colors of the bars indicate the PF values of the Abs, measured on the
AD8 Env.
(C) Correlation between the effects of ER on inhibition by each Ab for the
J3Hx(197,HT,N)-J3Hx(197) pair and the HXBc2-HXBc2(DQR) pair.
(D) Correlation between the PF values measured on the AD8 and
HXBc2(DQR) Envs.
(E) Correlation between PF of Abs measured on the AD8 Env and fold increase
in neutralizing potency (1/IC50) for HXBc2(DQR). Abs are colored according to
PF values, measured on the AD8 Env. Spearman rank-order correlation co-
efficient, rS; p value, two-tailed t test. Figure 4 is related to Figure S2.
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Env and Antibody Factors in HIV-1 Neutralizationof binding to the Env trimer; the lower the binding efficiency of the
Ab, the larger the effect of ER on inhibition (Figure 3C). As ex-
pected from the relationship of Env trimer binding and PF (Fig-
ure 2B), there was a very strong correlation between the PF of
each Ab and the impact of changes in ER on Ab neutralization
potency (Figure 3D). Thus, the more conformational perturbation
of Env that is required for Ab binding, the stronger the inhibition
of viruses with the perturbation-sensitive (high-ER) Envs, relative
to the inhibition of viruses with the perturbation-resistant (low-
ER) Envs. In summary, if an Ab can bind to Env, the PF of the
Ab modulates the contribution of the ER to virus neutralization.
Binding and Neutralization Profiles of the High-ER
HXBc2 Env and a Low-ER Variant
Laboratory adaptation of HIV-1 is often associated with acquisi-
tion of increased sensitivity to neutralizing Abs (Mascola et al.,Cell Host &1996; Moore et al., 1995; Pugach et al., 2004; Wrin et al.,
1995). HXBc2 is a laboratory-adapted strain of HIV-1 that has
a high-ER Env and, therefore, is relatively sensitive to Ab neutral-
ization (Haim et al., 2011). We found that deletion of a pair of res-
idues (Gln-Arg) in the gp120 V3 variable region rendered the
resulting virus, HXBc2(DQR), more resistant to neutralization
by most Abs (Figure 4A). These changes in sensitivity were not
caused by a general decrease in the binding of the Abs to Env tri-
mers (Figure 4A); moreover, relative to HXBc2, the HXBc2(DQR)Microbe 14, 547–558, November 13, 2013 ª2013 Elsevier Inc. 551
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Figure 5. Explanatory Capability of Different Models of HIV-1 Neutralization
(A) Correlations between themeasured relative neutralization sensitivity of HXBc2 and HXBc2(DQR) viruses and the relative neutralization sensitivity predicted by
a model based on Equation 2 (top panel) or a model based only on Ab-Env binding (bottom panel).
(B) Correlations between predicted andmeasured levels of inhibition. Nine closely matched variants of the AD8 Env that differ in ERwere tested for their sensitivity
to each of the indicated Abs. For each Ab, we show the correlation between the measured neutralization sensitivity and the neutralization sensitivity predicted by
models based on Ab-Env binding alone, ER alone, or the multiple parameters in Equation 2. Spearman rank-order correlation coefficients are reported and are
colored according to the strength of the correlation, as detailed in the key.
(legend continued on next page)
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tion (data not shown). Therefore, the HXBc2 and HXBc2(DQR)
variants are closely matched viruses that apparently differ in
ER. Presumably, the presence of the Gln-Arg residues in the
HXBc2 V3 region influences the conformation of the trimer asso-
ciation domain (TAD) (Mao et al., 2013), which is located at the
apex of the Env trimer, is composed of the V1/V2 and V3 regions
of gp120, and can influence the level of ER (Haim et al., 2011).
Similar to the pattern observed with the J3Hx(197,HT,N) and
J3Hx(197) viruses, neutralization by some Abs was dramatically
affected by changes in ER, as indicated by the difference
between the IC50 values for the HXBc2 and HXBc2(DQR) vari-
ants (Figures 4A and 4B). Furthermore, there was a striking cor-
relation between the J3Hx(197)-J3Hx(197,HT,N) pair and the
HXBc2-HXBc2(DQR) pair with respect to the effect of ER
changes on inhibition by each Ab (Figure 4C). Therefore, some
Abs are unaffected by the level of Env reactivity and inhibit
both high-ER and low-ER Envs similarly, whereas other Abs
are significantly affected by the level of Env reactivity and pri-
marily inhibit high-ER Envs. This quantitative relationship be-
tween Ab and the effect of ER is maintained in the context of
different Envs, supporting the suggestion that a property of
the Ab is involved.
We measured the sampling frequency associated with the
binding of different Abs to the HXBc2(DQR) Env and calculated
the PF values for each Ab. As expected, the Ab PF values
measured with the HXBc2(DQR) Env correlated well with those
calculated using the AD8 and JRFL Envs (Figure 4D). Further-
more, the PF of each Ab correlated well with the difference in
IC50 values for neutralization of the HXBc2 versus HXBc2(DQR)
viruses (Figure 4E). Interestingly, the rank order of the calculated
PF values was maintained despite very different efficiencies of
binding of some Abs. For example, although the PGT121 and
PGT128 Abs bound very poorly to HXBc2 and HXBc2(DQR)
Envs, and therefore did not inhibit these viruses, their PFs were
identical to those measured using other Envs that bound these
Abs with high efficiency (Figure S2). That the PF values are
consistent in the context of different Envs despite very different
binding efficiencies further supports the hypotheses that: (i) the
PF is primarily a property of the Ab and (ii) epitope integrity and
PF are two factors that independently affect binding and, thus,
neutralization.
A General Expression that Describes HIV-1 Inhibition
by Ab
We derived an expression that accounts for the above observa-
tions and predicts the neutralization of a range of HIV-1 isolates
by diverse Abs. Neutralization can be thought of as a result of Ab
binding to the HIV-1 Env trimer as well as the consequences of
Ab binding.
neutralizationfAb-Env binding3consequences of Ab binding
(1)(C) Correlations between the measured neutralization sensitivity of the nine AD8 va
(lower row) and the neutralization sensitivity predicted by a model based on Ab-E
quantitative comparison of the neutralization obtained with different Abs, all da
calculated value relative to the value obtained for the AD8 Env, which is assigned a
test. The PF values of the Abs used for the calculations in this figure were measu
Cell Host &The consequences of Ab binding to the HIV-1 Env trimer
depend upon ER, which we have found to be modulated by
the PF. Thus,
neutralizationfðAb-Env bindingÞ3 ðERÞPF: (2)
To test the validity of this expression, we first studied the
neutralization of the HXBc2 and HXBc2(DQR) variants described
above, which differ in ER, by the panel of Abs. We examined the
correlation between the measured neutralization sensitivity of
viruses containing these Envs and the neutralization sensitivity
predicted either by Ab-Env binding measurements alone or by
the combined contributions of Ab-Env binding, ER andPF (Equa-
tion 2). As shown in Figure 5A, the correlations between the pre-
dicted and measured values of neutralization were significantly
stronger when all three parameters were used in the prediction.
Furthermore, Equation 2 allowed an accurate prediction of the
absolute increase in sensitivity caused by given changes in ER,
PF, and binding. These results suggest that Equation 2 accu-
rately incorporates the factors that affect inhibition of HIV-1 by
Abs and describes the relationships among them.
To further test the accuracy of our model, we examined a
panel of nine closely matched variants of the AD8 Env (Haim
et al., 2011). These variants differ in the level of ER and, in a
few cases, in the integrity of specific epitopes. This allowed us
to examine the model accuracy when both binding and ER are
changing. Neutralization of all the virus variants by different
monoclonal Abs and CD4-Ig was tested. Wemeasured the bind-
ing of the Abs to the Env variants expressed on HOS cell sur-
faces. Finally, we assessed the ER of each variant by measuring
sCD4 reactivity (Haim et al., 2011). For each Ab tested, we exam-
ined the correlation for the entire panel of Envs between the
measured neutralization sensitivity and three different potential
predictors of neutralization: (i) Ab-Env binding, (ii) Env reactivity,
and (iii) the expression in Equation 2. The Spearman rank-order
coefficients for the different correlations were compared asmea-
sures of the predictive value of each expression for virus neutral-
ization by each Ab (Figure 5B). For the Abs examined, Equation 2
explained the neutralization data as well as or better than Ab-Env
binding or ER alone, with only a few exceptions. For example, the
binding of the b12 and VRC01 Abs, which target the CD4 binding
site, is decreased by the N197S change in gp120. Consequently,
Envs in the panel that contain Ser197 exhibited significantly
reduced binding of these Abs, which was directly reflected by
poor neutralization. Thus, for b12 and VRC01, there was a very
good correlation between Ab-Env binding and inhibition.
Furthermore, the relatively low PF of these Abs minimized the
contribution of Env reactivity to virus neutralization. Nonetheless,
even in these cases, Equation 2 performed onlymarginally worse
than binding alone as a predictor of virus inhibition.
The relationships between the neutralization data from this
panel of nine AD8 Env variants and either Ab-Env binding or
Equation 2 were examined separately for the low-PF and high-
PF Abs. For both low-PF and high-PF Abs, an excellentriants to the low-PF Abs (upper row), the high-PF Abs (middle row), and all Abs
nv binding alone (left panels) or based on Equation 2 (right panels). To allow a
ta for each Env variant are expressed as the fold change in the measured or
value of 1. Spearman rank-order correlation coefficient, rS; p value, two-tailed t
red on the AD8 Env.
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AB
C
Figure 6. Reversibility of Ab-Env Binding
and HIV-1 Inhibition
(A) Sensitivity of viruses containing the indicated
Env to neutralization by the given Abs was
measured, and the concentration required for
neutralization of 90% of free virus (i.e., virus in
suspension) was determined.
(B) Viruses containing the indicated Envs were
bound to protein-binding plates and incubated
with the Abs at a concentration that neutralizes
90% of free virus. Cf2Th CD4+CCR5+ target cells
were then added to the viruses either in the pres-
ence of Ab or after washing the virus extensively.
The virus-cell mixture was then incubated at 37C
for 1 hr to allow entry, after which cells were
trypsinized to halt entry and further cultured for
2 days. Infectivity was measured by luciferase
activity. For the absolute infection values, see
Figure S3. The reversibility of inhibition was
calculated by dividing the infectivity of washed
virus by the infectivity of unwashed virus. Data are
represented as mean ± SEM.
(C) Correlation between the reversibility of inhibi-
tion of the J3Hx(197,HT,N) virus (corrected for the
reversibility of Ab-Env binding) and the PF
measured on the AD8 Env. Spearman rank-order
correlation coefficient, rS; p value, two-tailed t test.
Figure 6 is related to Figure S3.
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Env and Antibody Factors in HIV-1 Neutralizationcorrelation was found between the observed virus neutralization
and that predicted by Equation 2 (Figure 5C, right panels). By
contrast, Ab-Env binding alone accurately predicted neutraliza-
tion of the viruses by low-PF Abs, but not by high-PF Abs
(Figure 5C, left panels). In summary, incorporation of Ab-Env
binding, ER, and PF into amodel explains the inhibition of viruses
with a range of neutralization sensitivities by Abs with different
Env-binding characteristics.
Reversibility of Inhibition by High-PF and Low-PF Abs
Some high-PF Abs bound relatively weakly to the high-ER Envs
but inhibited the infectivity of the corresponding virus very effi-
ciently (Figures 3A and 4A). We hypothesized that inhibition of
high-ER viruses by the high-PF Absmay involve irreversible inac-
tivation; by contrast, inhibition by the low-PF Abs, even of high-
ER viruses, is effected by a reversible occupancy of the Env554 Cell Host & Microbe 14, 547–558, November 13, 2013 ª2013 Elsevier Inc.spike. To test these hypotheses, we
examined the reversibility of inhibition
for the different Abs and Envs. To this
end, we directly attached viruses to
protein-binding plates and could thus
wash the virus after exposure to Ab.
Infection of cells was measured either in
the presence of the Ab or after extensively
washing the virus following Ab exposure.
We compared the degree of inhibition of
the virus continuously exposed to the Ab
with the inhibition of virus that was
washed before cells were added. We in-
terpreted increases in the infectivity of
the washed samples to be indicative of
reversible inhibition.Binding the virus to the plate affected neither its infectivity nor
the concentration of Ab required to achieve 90% inhibition (Fig-
ure 6A and data not shown). Figures 6B and S3 show that some
Abs, such as the previously reported 2G12 Ab (Platt et al., 2012),
demonstrated high degrees of reversibility. The absence of an
effect of washes on inhibition could be attributed to either low
dissociation of Ab or to irreversible inactivation. We therefore
sought to normalize the reversibility of inhibition by measuring
the reversibility of virus binding, which can be quantitated by
the amount of Ab bound before washes relative to Ab bound
after washes. However, control experiments showed that the
level of Ab bound before the washes cannot be accurately deter-
mined due to high background relative to the signal.
As an alternative, we examined the binding of each Ab at a
concentration that induces a fixed level (90%) of virus neutraliza-
tion. We assume that for a given level of inhibition, the initial level
Figure 7. Model of HIV-1 Neutralization
by Abs
The efficiency of HIV-1 neutralization is deter-
mined by the capacity of the Ab to engage Env and
to modulate its conformation. Themetastable HIV-
1 Env is maintained in a high-potential-energy
state by activation energy barriers. The magnitude
of these activation barriers determines the degree
of Env reactivity (ER), which is defined as the
propensity of Env to transition to lower-energy
states upon perturbation. The sampling frequency
of the Env conformations capable of binding each
Ab reflects the degree of structural change
(perturbation) required to achieve these confor-
mations from the basal state of unliganded Env.
Abs with low perturbation factors (PF; colored
blue and green) recognize lower-energy (highly
sampled) conformations and inhibit infection by
reversibly preventing transitions down the pro-
ductive (entry) pathway. Such low-PF Abs are less
affected by the level of ER because little confor-
mational perturbation of Env is required for bind-
ing. Inhibition by high-PF Abs (colored orange and
red) is primarily determined by the level of ER
because inhibition is mainly effected by promoting
irreversible transitions down nonproductive path-
ways.
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(for reversible inhibition) or detach (for irreversible inhibition).
As the level of binding before the washes is adjusted to be con-
stant in all samples, we can quantitate the relative reversibility of
binding by measuring the amount of Ab bound after the washes
(see detailed description in the Supplemental Experimental
Procedures).
The impact of PF on the reversibility of inhibitionwas examined
using the high-ER Env J3Hx(197,HT,N), which is susceptible to
neutralization by high-PF and low-PF Abs. A very strong inverse
correlation was observed between the reversibility of inhibition
(corrected for the reversibility of binding) and the PF of each
Ab (Figure 6C). That reversibility of neutralization is a continuous,
rather than binary, variable suggests that some Abs inhibit virus
infection by both reversible and nonreversible mechanisms.
Thus, high-PF Abs can inhibit low-ER Envs but require high
concentrations to do so, presumably to achieve the necessary
level of Env occupancy (see inhibition of AD8 and JR-FL by
2F5 in Figures 6A and 6B). Inhibition of these low-ER viruses
by this high-PF Ab was reversible, whereas its inhibition of the
high-ER J3Hx(197,HT,N) virus was nonreversible. Thus, some
Abs can inhibit by both occupancy- and perturbation-based
mechanisms.
DISCUSSION
The HIV-1 Env trimer is a high-potential-energy molecular ma-
chine. Receptor binding releases the energy stored in Env to
drive virus-cell membrane fusion and virus entry (Blumenthal
et al., 2012). Because premature loss of the potential energy of
unliganded Env would result in functional inactivation, this meta-
stable state of Env must be maintained until receptor engage-
ment at the target cell surface. Activation energy barriers, formed
by the interactions that maintain the structural integrity of the un-Cell Host &liganded state of the trimer, prevent the metastable Env from
transitioning to lower-energy, functional or nonfunctional states
(Figure 7). The magnitude of these activation energy barriers de-
termines ER, which influences both HIV-1 activation (by CD4)
and inactivation (by Abs, other inhibitory ligands, or exposure
to cold) (Haim et al., 2011).
HIV-1 neutralization represents the product of Ab binding
to the Env trimer and the consequences of that binding. Each
of these factors is potentially influenced by viral and Ab vari-
ables. Ab binding to the Env trimer depends upon the affinity
of the Ab for its unconstrained epitope and upon the degree
of conformational change in the Env trimer required for Ab
binding. The latter property, PF, can be assessed by measuring
Ab binding to GA-crosslinked versus untreated cell-surface
HIV-1 Env trimers. The crosslinking analysis provides an indica-
tion of the relative occupancy of different conformational states
by the unliganded HIV-1 Env trimer (Yuan et al., 2006). The rela-
tive free energies of these conformational states can be calcu-
lated based on the Boltzmann distribution (Guggenheim, 1955).
The conformations favored by the low-PF Abs are lower in
energy and are sampled more frequently by the unliganded
Env trimer; conversely, the conformations favored by the
high-PF Abs have high free energies and are sampled less
frequently (Figure 7). In this view, the major Env conformations
(unliganded, CD4 bound, coreceptor bound, fusion active)
consist of a collection of conformers, each with a characteristic
energy, sampling frequency, and ability to be recognized by
particular ligands. Some of the Env conformers in the unli-
ganded state presumably share structural features with con-
formers in the CD4-bound state; for example, Abs against
CD4-induced epitopes can still recognize Env fixed in the unli-
ganded state, albeit at a low efficiency. The many different
states of Env contribute to the apparently continuous nature
of the PF variable.Microbe 14, 547–558, November 13, 2013 ª2013 Elsevier Inc. 555
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ER, the reciprocal of the PF predicts neutralization as well as
or better than equilibrium Ab-Env binding, consistent with the
importance of Ab on-rate to Env trimer binding and HIV-1-
neutralizing potency (Sattentau and Moore, 1995; Steckbeck
et al., 2005). Under these circumstances, Ab-Env binding in
Equation 2 can be replaced as follows:
neutralizationfðepitope integrity = PFÞ3 ðERÞPF: (3)
Equation 3 suggests that the PF of the Ab affects neutralization
in opposite ways, depending upon the ER of the virus. For low-
ER viruses, Ab-Env binding is the dominant determinant of
neutralization; this situation favors Abs with low PF values that
can achieve high on-rates. For viruses with high ER, the degree
of structural perturbation of Env required for Ab binding to the
Env trimer represents the dominant determinant of neutraliza-
tion; this situation favors Abs with high PF values, which can
trap the highly reactive Envs in conformations that are prone to
irreversible inactivation.
For the neutralization of the majority of naturally occurring
HIV-1 strains with low ER values, the negative contribution of
PF to Env trimer binding outweighs the potentially positive
contribution of PF to the consequences of Ab binding. In this
situation, the epitopes recognized by weakly neutralizing (high-
PF) Abs are unavailable and not easily induced on the Env trimer
(Figure 7). By contrast, potently neutralizing (low-PF) Abs do not
require the unliganded Env trimer to change significantly in struc-
ture for efficient binding to occur. For example, potently neutral-
izing Abs directed against the CD4-binding site (CD4BS) of
gp120 recognize the unliganded state of the HIV-1 Env trimer
more effectively than less potently neutralizing Abs targeting
this gp120 region (Chen et al., 2009). Such differences in binding
to the intact trimer spike among the b12, b13, and F105 Abswere
indeed reflected in their PF values. Even though some potent
CD4BS Abs like VRC01 can induce the CD4-bound state in
monomeric gp120, this induced conformational change is not
necessary for efficient Env trimer binding (Zhou et al., 2010).
Thus, the inhibitory capacity of an Ab for most primary HIV-1 iso-
lates is predominantly determined by the degree of perturbation
of Env conformation that is required for its binding.
In addition to Ab binding efficiency to Env, HIV-1 neutralization
is also influenced by the consequences of Ab binding (i.e., the
degree of perturbation of Env structure associated with Ab bind-
ing). The contribution of this factor to HIV-1 neutralization is
strongly influenced by properties of both virus and Ab. HIV-1
strains differ in their requirements for the level of CD4 on target
cells, and CD4 dependence is inversely related to general
neutralization sensitivity (Kolchinsky et al., 2001b; Zhang et al.,
2002). This relationship between CD4 independence and
neutralization sensitivity is explained by differences in ER
(Haim et al., 2011). ER is defined as the propensity of Env to un-
dergo conformational changes when perturbed by ligand bind-
ing or exposure to cold. Although the PF formally describes the
degree of Env conformational changes that is required for Ab
engagement, and not necessarily the degree of change that is
induced by the Ab, the binding of high-PF Abs is expected to
trap Env in less-favored conformational states and, thus, to
modulate Env conformation. It is satisfying to observe that the556 Cell Host & Microbe 14, 547–558, November 13, 2013 ª2013 ElsPF, an Ab property that governs the impact of ER on neutraliza-
tion, reflects the ability of the Ab to perturb Env conformational
states. In this light, CD4 and CCR5 can be viewed as perturbing
factors that disrupt metastable Env states to drive the entry pro-
cess. How natural HIV-1 variants regulate their reactivity to the
receptors versus Abs will be of great interest in future studies.
That Abs can promote inhibitory consequences beyond Env
trimer binding is supported by the apparent irreversibility of
HIV-1 neutralization in some instances. Irreversible inhibition
was associated with neutralization of high-ER viruses by high-
PF Abs. This observation suggests that the induction of Env
conformational change by Ab binding is important for irreversible
virus inactivation. Ab-inducedmovement of Env frommetastable
states to lower-energy states could explain the irreversibility of
the inhibitory effect (Figure 7). Such a mechanism is reminiscent
of the premature transition of Env to the labile CD4-bound state
that underlies the irreversible inhibition of HIV-1 entry seen for
some small-molecule CD4-mimetic compounds or soluble forms
of CD4 (Haim et al., 2009).
The relationship betweenHIV-1 neutralization and binding, PF,
and ER implied by Equation 2 does not take into account the
specific Env binding site of the Ab. Hypothetically, Ab binding
to functional elements of Env might result in a gain in neutraliza-
tion potency. For example, an Ab that competes with CD4 might
be more effective in neutralizing HIV-1 than an Ab that binds a
nonfunctional element on the Env trimer. However, consideration
of the above three factors in Equation 2 accurately explains the
sensitivity of a wide range of HIV-1 variants to inhibition by Abs
of different potencies. The steric effects of trimer-bound Ab on
the fusion of the viral and target cell membranes may be much
more significant than the specific impact of Ab binding to its
epitope (Yang et al., 2006). Should future work demonstrate
that binding to a specific Env element results in more effective in-
hibition of HIV-1 entry, Equation 2 can be modified to include
such a factor. Similarly, incorporation of the stoichiometry of
Ab engagement of the Env trimer, which may differ among Abs
(Lo¨ving et al., 2013; Yang et al., 2005), may improve the precision
of the above expression.
Our findings quantitatively describe two separate pathways
that allow inactivation of Env function, through Ab engagement
of the functional Env spike and through perturbation of Env struc-
ture. This basic mechanistic understanding should assist efforts
to design immunogens for an AIDS vaccine and inhibitors of
HIV-1 entry into cells.
EXPERIMENTAL PROCEDURES
Full methods are available in the Supplemental Experimental Procedures.
Abs and Soluble Forms of CD4
The broadly neutralizing Abs b12 and VRC01 recognize the CD4-binding site of
gp120 (Chen et al., 2009; Zhou et al., 2010). The b6, b13, and F105 Abs also
target the CD4-binding site but generally do not neutralize primary HIV-1 iso-
lates efficiently (Chen et al., 2009). The 17b and 48d Abs recognize gp120 epi-
topes that are induced by CD4 binding. Ab 3BC176 targets a still incompletely
defined gp120 epitope that is exposed in part by CD4 binding. Abs 2F5, 4E10,
and 10E8 recognize the membrane-proximal external region (MPER) of gp41.
The 2G12, PG9, PG16, PGT121, and PGT128 Abs recognize glycan-depen-
dent epitopes on gp120.
The CD4-Ig fusion protein is composed of the constant fragment (Fc) region
of human IgG1 linked to two copies of the two N-terminal domains of the CD4evier Inc.
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Env and Antibody Factors in HIV-1 Neutralizationmolecule. The soluble form of CD4 (sCD4) is composed of domains D1–D4 of
this molecule and was purified as previously described (Haim et al., 2011).
Env Constructs
The Envs of the AD8, JR-FL, and HXBc2 isolates of HIV-1 (accession numbers
AF004394, U63632, and K03455, respectively) were expressed from the
pSVIIIenv vector. The J3Hx(197) variant is a chimera between the Envs of the
AD8 and HXBc2 strains and contains an Asn-to-Ser change at position 197
(Haim et al., 2011; Kolchinsky et al., 2001b). The J3Hx(197,HT,N) construct is
identical to J3Hx(197), except for additional changes: Env residues 625 and
626 are changed fromAsn-Met toHis-Thr andEnv residue 674 fromAsp toAsn.
The Hx(DQR) construct contains a deletion of the amino acid residues
Gln310-Arg311 at the tip of the V3 loop of the HXBc2 Env. The Envs of three
transmitted/founder HIV-1 subtype C viruses were studied: isolate ZM249M
from Zambia, isolate 704809221 from South Africa, and isolate 703010217
from Malawi (accession numbers EU166862, FJ444116, and FJ443589,
respectively).
Complete descriptions of the antibodies and Env variants can be found in
the Supplemental Experimental Procedures.
Cell-Based ELISA
HOS cells were seeded in 96-well plates and transfected the next day with
0.06 mg of an Env-expressing plasmid and 0.008 mg of a Tat-expressing
plasmid per well using Effectene reagent, as previously described (Haim
et al., 2011). Then, 3 days later, cells were incubated with the indicated primary
Ab for 30min at 37C. Cells were then washed and incubated with a secondary
horseradish peroxidase (HRP)-conjugated Ab for 45 min at room temperature.
Cells were washed, and HRP enzyme activity was determined after the addi-
tion ofWestern Lightning Reagents (PerkinElmer) with aMithras LB 940 Lumin-
ometer (Berthold Technologies).
GA Fixation of Cell Surface Env
HOS cells transfected 3 days earlier with the indicated Envs were washed
twice with fixation buffer (140 mM NaCl, 1.8 mM CaCl2, 1 mM MgCl2, and
10 mM HEPES [pH 7.4]) and then incubated with fixation buffer containing
5 mM GA for 15 min at room temperature. As controls, some samples were
incubated with fixation buffer with no GA added. GA activity was halted by
the addition of 25 mM glycine in fixation buffer, which was added to all sam-
ples. Subsequently, fixed and nonfixed samples were examined for binding
of Abs, using the cell-based ELISAmethod described above. Complete details
can be found in the Supplemental Experimental Procedures.
Measurement of the On-Rate of Ab Binding to Cell Surface Env
HOS cells cultured in 96-well plates were transfected with the AD8 Env-
expressing plasmid. Then, 3 days later, cells were incubated with different
Abs at 5 mg/ml for different time periods, from 2 to 45 min. After incubation
of the last sample, all samples were washed, and Ab binding was measured
using an HRP-conjugated secondary Ab, as described above.
Neutralization of Recombinant HIV-1
Single-round, recombinant HIV-1 viruses that express the luciferase gene
were generated by transfection of 293T cells, as described (Haim et al.,
2011). For neutralization tests, viruses were exposed to Abs for 1 hr at 37C
prior to the addition of target cells, either CD4+CCR5+ or CD4+CXCR4+
Cf2Th cells. After 2 days at 37C, luciferase activity in the target cells was
measured. Details of the neutralization assays can be found in the Supple-
mental Experimental Procedures.
Reversibility of Ab Binding and Inhibition
Recombinant HIV-1 expressing luciferase was purified by ultracentrifugation
through a 30% sucrose cushion and then spinoculated onto 96-well protein-
binding plates (PerkinElmer). Plate-bound viruses were then incubated with
Ab (plus HRP-conjugated protein G for binding assays) at a 90% inhibitory
concentration for 2 hr at 37C. The virus-Ab complexes were washed exten-
sively before measuring bound Ab (HRP) or adding target cells and measuring
infection (luciferase), as described above. Details can be found in the Supple-
mental Experimental Procedures.Cell Host &SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at http://dx.doi.
org/10.1016/j.chom.2013.10.006.
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